BioSpace News Archive

The Audacious Project, an initiative housed at TED, encourages the world’s greatest changemakers to dream bigger.

Smart Meter, the number one supplier of remote patient monitoring devices, data, and services, supporting a nationwide network of SmartPartners, announces three new products at the HIMSS Global Conference in Chicago.

City of Hope will showcase breakthrough research and innovative studies at this year’s American Association for Cancer Research (AACR) Annual Meeting, which takes place April 14 to 19 in Orlando, Florida.

Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”) today announced that it will present preclinical data in two poster presentations highlighting the Company’s novel Hippo pathway inhibitor, IK-930, at the American Association for Cancer Research (AACR) Annual Meeting taking place in Orlando, FL from April 14-19, 2023.

ZielBio, Inc. will present new, preclinical data showing that its lead asset, ZB131, directed against cancer-specific plectin (CSP), represents a promising approach for antibody-drug conjugates (ADCs) at the American Association for Cancer Research (AACR) Annual Meeting 2023.

Precigen, Inc. (Nasdaq: PGEN) today presents preclinical data for the next generation UltraCAR-T platform utilizing MSLN CAR from Precigen’s library of non-viral plasmids at the American Association for Cancer Research (AACR) Annual Meeting 2023.

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today provided an update from its CEO, Alon Ben-Noon, on the Company’s clinical and operational developments during the first quarter of 2023.

Imvax, Inc. today announced a poster presentation providing additional mechanistic insights into its Goldspire™ platform based on preclinical studies of its lead product candidate, IGV-001, for the treatment of glioblastoma (GBM).

Fresenius Kabi announced today its Ivenix Infusion System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company.

Halda Therapeutics today announced a poster presentation for its lead RIPTAC therapeutic program for prostate cancer at the annual meeting of the American Association for Cancer Research (AACR) being held in Orlando, Florida, from April 14-19, 2023.